Heavy-metal toxicity - With emphasis on mercury

Integrative Medicine

Volumn 6, Issue 2, 2007, Pages 26-32

  Neustadt, John ^a,b,c,d   Pieczenik, Steve ^e,f  

^a Montana Integrative Medicine   (United States)

^b NBI Testing and Consulting Corp   (United States)

^c Dragon Arts Publishing   (United States)

^d Metametrix Inc   (United States)

^e NBI ^*

^f Montana Integrative Medicine

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; GARLIC EXTRACT; SILYMARIN; SUCCIMER; THIOCTIC ACID;

ARSENIC POISONING; CADMIUM POISONING; CHINESE MEDICINE; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; HEAVY METAL POISONING; HUMAN; LEAD POISONING; MERCURIALISM; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; RISK ASSESSMENT; RISK FACTOR; TOXICITY TESTING; TOXICOKINETICS;

EID: 39749152224     PISSN: 1546993X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Ibrahim D, Froberg B, Wolf A, Rusyniak DE. Heavy metal poisoning: clinical presentations and pathophysiology. Clin Lab Med. 2006;26(1):67-97, viii.
2. Calderon J, Ortiz-Perez D, Yanez L, Diaz-Barriga F. Human exposure to metals. Pathways of exposure, biomarkers of effect, and host factors. Ecotoxicol Environ Saf. 2003;56(1):93-103.
3. Graeme KA, Pollack CV Jr. Heavy metal toxicity, Part I: arsenic and mercury. J Emerg Med. 1998;16(1):45-56.
4. Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev. 2000;52(1):113-143.
5. Guzzi G, Minoia C, Pigatto PD, Severi G. Methylmercury, amalgams, and children's health. Environ Health Perspect. 2006;114(3):A149; author reply A149-150.
6. Bertilsson L, Neujahr HY. Methylation of mercury compounds by methyl-cobalamin. Biochemistry. 1971;10(14):2805-2808.
7. Bachanek T, Staroslawska E, Wolanska E, Jarmolinska K. Heavy metal poisoning in glass worker characterised by severe. Ann Agric Environ Med. 2000;7(1):51-53.
8. Caussy D. Case studies of the impact of understanding bioavailability: arsenic. Ecotoxicol Environ Saf. 2003;56(1):164-173.
9. Ernst E, Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther. 2001;70(6):497-504.
10. Peakall D, Burger J. Methodologies for assessing exposure to metals: speciation, bioavailability of metals, and ecological host factors. Ecotoxicol Environ Saf. 2003;56(1):110-121.
11. Zheng W, Aschner M, Ghersi-Egea JF. Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol. 2003;192(1):1-11.
12. Pamphlett R, Waley P. Motor neuron uptake of low dose inorganic mercury. J Neurol Sci. 1996;135(1):63-67.
13. Gochfeld M, Burger J. Good fish/bad fish: a composite benefit-risk by dose curve. Neurotoxicology. 2005;26(4):511-520.
14. Crinnion WJ. Environmental medicine, part three: long-term effects of chronic low-dose mercury exposure. Altern Med Rev. 2000;5(3):209-223.
15. Kerper LE, Ballatori N, Clarkson TW. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol. 1992;262(5 Pt 2):R761-765.
16. Simmons-Willis TA, Koh AS, Clarkson TW, Ballatori N. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem J. 2002;367(Pt 1):239-246.
17. Custodio HM, Harari R, Gerhardsson L, Skerfving S, Broberg K. Genetic influences on the retention of inorganic mercury. Arch Environ Occup Health. 2005;60(1):17-23.
18. Custodio HM, Broberg K, Wennberg M, et al. Polymorphisms in glutathione-related genes affect methylmercury retention. Arch Environ Health. 2004;59(11):588-595.
19. Berndt WO. The role of transport in chemical nephrotoxicity. Toxicol Pathol. 1998;26(1):52-57.
20. Crinnion WJ. Environmental medicine, part one: the human burden of environmental toxins and their common health effects. Altern Med Rev. 2000;5(1):52-63.
21. Van Wijngaarden E, Beck C, Shamlaye CF, et al. Benchmark concentrations for methyl mercury obtained from the 9-year follow-up of the Seychelles Child Development Study. Neurotoxicology. 2006;27(5):702-709.
22. Kim EH, Kim IK, Kwon JY, Kim SW, Park YW. The effect of fish consumption on blood mercury levels of pregnant women. Yonsei Med J. 2006;47(5):626-633.
23. What you need to know about mercury in fish and shellfish. Available at:http://www.epa.gov/waterscience/fishadvice/advice.html. Accessed December 5, 2006.
24. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292(23):2868-2873.
25. Shrestha M, Greenberg MI. Lead poisoning derived from Ayurvedic medication.(Abstract). (Abstract). 2002;40(5):678(671).
26. Caraccio TR, McGuigan M, Mofenson HC. Chronic arsenic (As) toxicity from Chitosan[R] supplement.(Abstract). (Abstract). 2002;40(5):644(641).
27. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-1208.
28. Sanfeliu C, Sebastia J, Ki SU. Methylmercury neurotoxicity in cultures of human neurons, astrocytes, neuroblastoma cells. Neurotoxicology. 2001;22(3):317-327.
29. Bralley J, Lord R. Chapter 6: Organic Acids. Laboratory Evaluations in Molecular Medicine: Nutrients, Toxicants, and Cell Regulators. Norcross, GA: The Institute for Advances in Molecular Medicine; 2001:175-208.
30. Brown AC, Bullock CG, Gilmore RS, Wallace WF, Watt M. Mitochondrial granules: are they reliable markers for heavy metal cations? J Anat. 1985;140 (Pt 4):659-667.
31. Kaur P, Aschner M, Syversen T. Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology. 2006;27(4):492-500.
32. Yee S, Choi BH. Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology. 1996;17(1):17-26.
33. Chen YW, Huang CF, Tsai KS, et al. Methylmercury induces pancreatic beta-cell apoptosis and dysfunction. Chem Res Toxicol. 2006;19(8):1080-1085.
34. Lund BO, Miller DM, Woods JS. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 1993;45(10):2017-2024.
35. Neustadt J. Mitochondrial dysfunction and disease. Integr Med. 2006;5(3):14-20.
36. Ramanathan K, Shila S, Kumaran S, Panneerselvam C. Ascorbic acid and alpha-tocopherol as potent modulators on arsenic induced toxicity in mitochondria. J Nutr Biochem. 2003;14(7):416-420.
37. Belyaeva EA, Korotkov SM. Mechanism of primary Cd2+-induced rat liver mitochondria dysfunction: discrete modes of Cd2+ action on calcium and thiol-dependent domains. Toxicol Appl Pharmacol. 2003;192(1):56-68.
38. Kazantzis G. Cadmium, osteoporosis and calcium metabolism. Biometals. 2004;17(5):493-498.
39. Naranmandura H, Suzuki N, Suzuki KT. Trivalent arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol. 2006;19(8):1010-1018.
40. Li JJ, Tang Q, Li Y, et al. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol Sin. 2006;27(8):1078-1084.
41. Winker R, Rudiger HW. Reproductive toxicology in occupational settings: an update. Int Arch Occup Environ Health. 2006;79(1):1-10.
42. Stavrides JC. Lung carcinogenesis: Pivotal role of metals in tobacco smoke. Free Radic Biol Med. 2006;41(7):1017-1030.
43. [Monograph] Meso-2,3-Dimercaptosuccinic acid (DMSA). Alt Med Rev. 2000;5(3):264-267.
44. Murugavel P, Pari L, Sitasawad SL, Kumar S, Kumar S. Cadmium induced mitochondrial injury and apoptosis in vero cells: protective effect of diallyl tetrasufide from garlic. Int J Biochem Cell Biol. 2007;39(1):161-170.
45. Middleton N, Jelen P, Bell G. Whole blood and mononuclear cell glutathione response to dietary whey protein supplementation in sedentary and trained male human subjects. Int J Food Sci Nutr. 2004;55(2):131-141.